News
Morgan Stanley has lowered its price target on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) to $755 from $958, while ...
4h
Zacks Investment Research on MSNMorgan Stanley (MS) Gains But Lags Market: What You Should KnowMorgan Stanley (MS) closed at $128.68 in the latest trading session, marking a +0.22% move from the prior day. The stock lagged the S&P 500's daily gain of 0.58%. Elsewhere, the Dow saw an upswing of ...
Indian benchmark indices, Sensex and Nifty, traded lower on Tuesday as worries over global trade tensions dampened investor ...
9h
TipRanks on MSNLloyds Banking Group Enhances Shareholder Value Through Share BuybackLloyds Banking ( ($GB:LLOY) ) just unveiled an update. Lloyds Banking Group PLC announced the purchase of over 12 million of its ordinary shares ...
January. Morgan Stanley strategists think a range of factors will send it lower in the coming months.
Morgan Stanley, a mega-cap financial titan with a $205.4 billion market cap, offers everything from M&A advisory to wealth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results